FDA: Valproate use in pregnancy leads to lower IQs in children
This article was originally published in Scrip
Executive Summary
The US FDA alerted prescribers and patients on 6 May that drugs containing the antiseizure agents valproate sodium, divalproex sodium and valproic acid should not be used by pregnant women to prevent migraine headaches – warning the medications can lead to lower IQs in children whose mothers took the drugs during pregnancy.